- Study by Kailash Thapaliya, PhD highlights increased GLP-1 RA prescriptions (2011-2022).
- 1% of 1.6 million women aged 18-49 received GLP-1 RAs; 21% had diabetes.
- Increase from 13 per 1,000 (2011) to 89 per 1,000 (2022) for diabetic patients.
- 91% of new prescriptions in 2022 were in non-diabetic women.
- Only 21% used contraception at initiation.
- Significant pregnancy rates observed, notably in younger demographic.
- Need for improved awareness and guidance for safe prescribing.
Source: The Medical Journal of Australia
